{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:40:44Z","timestamp":1780076444490,"version":"3.54.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,12,8]],"date-time":"2010-12-08T00:00:00Z","timestamp":1291766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00204-010-0626-5","type":"journal-article","created":{"date-parts":[[2010,12,7]],"date-time":"2010-12-07T11:39:56Z","timestamp":1291721996000},"page":"165-173","source":"Crossref","is-referenced-by-count":37,"title":["Nephrotoxicity of contrast media and protective effects of acetylcysteine"],"prefix":"10.1007","volume":"85","author":[{"given":"Carlo","family":"Briguori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Quintavalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"De Micco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerolama","family":"Condorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,8]]},"reference":[{"issue":"9","key":"626_CR1","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/sj.onc.1210220","volume":"26","author":"JM Adams","year":"2007","unstructured":"Adams JM, Cory S (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26(9):1234\u20131237","journal-title":"Oncogene"},{"issue":"3","key":"626_CR2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ccd.10323","volume":"57","author":"S Allaqaband","year":"2002","unstructured":"Allaqaband S, Tumuluri R, Malik AM, Gupta A, Volkert P, Shalev Y, Bajwa TK (2002) Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Interv 57(3):279\u2013283","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"626_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/j.ajkd.2003.09.009","volume":"43","author":"A Alonso","year":"2004","unstructured":"Alonso A, Lau J, Jaber BL, Weintraub A, Sarnak MJ (2004) Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis 43(1):1\u20139","journal-title":"Am J Kidney Dis"},{"key":"626_CR4","doi-asserted-by":"crossref","unstructured":"Amini M, Salarifar M, Amirbaigloo A, Masoudkabir F, Esfahani F (2009) N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial. Trials 10 (45)","DOI":"10.1186\/1745-6215-10-45"},{"issue":"11","key":"626_CR5","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00004424-199411000-00002","volume":"29","author":"KJ Andersen","year":"1994","unstructured":"Andersen KJ, Christensen EI, Vik H (1994) Effects of iodinated x-ray contrast media on renal epithelial cells in culture. Invest Radiol 29(11):955\u2013962","journal-title":"Invest Radiol"},{"issue":"2","key":"626_CR6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archinte.166.2.161","volume":"166","author":"SM Bagshaw","year":"2006","unstructured":"Bagshaw SM, McAlister FA, Manns BJ, Ghali WA (2006) Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence. Arch Intern Med 166(2):161\u2013166","journal-title":"Arch Intern Med"},{"issue":"12","key":"626_CR7","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/S0735-1097(03)00487-X","volume":"41","author":"CS Baker","year":"2003","unstructured":"Baker CS, Wragg A, Kumar S, De Palma R, Baker LR, Knight CJ (2003) A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 41(12):2114\u20132118","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"626_CR8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1148\/radiology.175.1.2315505","volume":"175","author":"GL Bakris","year":"1990","unstructured":"Bakris GL, Gaber AO, Jones JD (1990a) Oxygen free radical involvement in urinary Tamm-Horsfall protein excretion after intrarenal injection of contrast medium. Radiology 175(1):57\u201360","journal-title":"Radiology"},{"issue":"1 Pt 2","key":"626_CR9","first-page":"F115","volume":"258","author":"GL Bakris","year":"1990","unstructured":"Bakris GL, Lass N, Gaber AO, Jones JD, Burnett JCJ (1990b) Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol 258(1 Pt 2):F115\u2013F120","journal-title":"Am J Physiol"},{"issue":"1","key":"626_CR10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1148\/radiology.188.1.8511292","volume":"188","author":"BJ Barrett","year":"1993","unstructured":"Barrett BJ, Carlisle EJ (1993) Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188(1):171\u2013178","journal-title":"Radiology"},{"issue":"6","key":"626_CR11","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/ki.1995.249","volume":"47","author":"R Beeri","year":"1995","unstructured":"Beeri R, Symon Z, Brezis M, Ben-Sasson SA, Baehr PH, Rosen S, Zager RA (1995) Rapid DNA fragmentation from hypoxia along the thick ascending limb of rat kidneys. Kidney Int 47(6):1806\u20131810","journal-title":"Kidney Int"},{"issue":"9384","key":"626_CR12","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0140-6736(03)14189-X","volume":"362","author":"R Birck","year":"2003","unstructured":"Birck R, Krzossok S, Markowetz F, Schn\u00fclle P, van der Woude FJ, Braun C (2003) Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 362(9384):598\u2013603","journal-title":"Lancet"},{"issue":"3","key":"626_CR13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ccd.10389","volume":"58","author":"F Boccalandro","year":"2003","unstructured":"Boccalandro F, Amhad M, Smalling RW, Sdringola S (2003) Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast. Catheter Cardiovasc Interv 58(3):338\u2013341","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"626_CR14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0735-1097(02)01958-7","volume":"40","author":"C Briguori","year":"2002","unstructured":"Briguori C, Manganelli F, Scarpato P, Elia PP, Golia B, Riviezzo G, Lepore S, Librera M, Villari B, Colombo A, Ricciardelli B (2002) Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 40(2):298\u2013303","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"626_CR15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/pcad.2003.YPCAD16","volume":"45","author":"C Briguori","year":"2003","unstructured":"Briguori C, Tavano D, Colombo A (2003) Contrast agent\u2013associated nephrotoxicity. Prog Cardiovasc Dis 45(6):493\u2013503","journal-title":"Prog Cardiovasc Dis"},{"issue":"4","key":"626_CR16","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jacc.2004.04.052","volume":"44","author":"C Briguori","year":"2004","unstructured":"Briguori C, Colombo A, Airoldi F, Violante A, Castelli A, Balestrieri P, Paolo Elia P, Golia B, Lepore S, Riviezzo G, Scarpato P, Librera M, Focaccio A, Ricciardelli B (2004a) N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity. J Am Coll Cardiol 44(4):762\u2013765","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"626_CR17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ehj.2003.11.016","volume":"25","author":"C Briguori","year":"2004","unstructured":"Briguori C, Colombo A, Violante A, Balestrieri P, Manganelli F, Paolo Elia P, Golia B, Lepore S, Riviezzo G, Scarpato P, Focaccio A, Librera M, Bonizzoni E, Ricciardelli B (2004b) Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 25(3):206\u2013211","journal-title":"Eur Heart J"},{"issue":"19","key":"626_CR18","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1161\/CIRCULATIONAHA.109.919639","volume":"121","author":"C Briguori","year":"2010","unstructured":"Briguori C, Visconti G, Rivera NV, Focaccio A, Golia B, Giannone R, Castaldo D, De Micco F, Ricciardelli B, Colombo A (2010) Cystatin C and contrast-induced acute kidney injury. Circulation 121(19):2117\u20132122","journal-title":"Circulation"},{"issue":"5","key":"626_CR19","doi-asserted-by":"crossref","first-page":"1032.e9","DOI":"10.1016\/j.ahj.2006.02.002","volume":"151","author":"LC Coyle","year":"2006","unstructured":"Coyle LC, Rodriguez A, Jeschke RE, Simon-Lee A, Abbott KC, Taylor AJ (2006) Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics. Am Heart J 151(5):1032.e9\u20131032.e12","journal-title":"Am Heart J"},{"issue":"3","key":"626_CR20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0002-9149(01)02243-3","volume":"89","author":"LJ Diaz-Sandoval","year":"2002","unstructured":"Diaz-Sandoval LJ, Kosowsky BD, Losordo DW (2002) Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 89(3):356\u2013358","journal-title":"Am J Cardiol"},{"issue":"3 Pt 2","key":"626_CR21","first-page":"F292","volume":"272","author":"J DiMari","year":"1997","unstructured":"DiMari J, Megyesi J, Udvarhelyi N, Price P, Davis R, Safirstein R (1997) N-acetyl cysteine ameliorates ischemic renal failure. Am J Physiol 272(3 Pt 2):F292\u2013F298","journal-title":"Am J Physiol"},{"issue":"7","key":"626_CR22","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/ndt\/gfh261","volume":"19","author":"LF Drager","year":"2004","unstructured":"Drager LF, Andrade L, Barros de Toledo JF, Laurindo FR, Machado C\u00e9sar LA, Seguro AC (2004) Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrol Dial Transpl 19(7):1803\u20131807","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"626_CR23","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1046\/j.1523-1755.2002.00673.x","volume":"62","author":"JD Durham","year":"2002","unstructured":"Durham JD, Caputo C, Dokko J, Zaharakis T, Pahlavan M, Keltz J, Dutka P, Marzo K, Maesaka JK, Fishbane S (2002) A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 62(6):2202\u20132207","journal-title":"Kidney Int"},{"issue":"7","key":"626_CR24","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/ndt\/gfm113","volume":"22","author":"S Efrati","year":"2007","unstructured":"Efrati S, Berman S, Siman-Tov Y, Lotan R, Averbukh Z, Weissgarten J, Golik A (2007) N-acetylcysteine attenuates NSAID-induced rat renal failure by restoring intrarenal prostaglandin synthesis. Nephrol Dial Transpl 22(7):1873\u20131881","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"626_CR25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.ASN.0000107562.68920.92","volume":"15","author":"S Fishbane","year":"2004","unstructured":"Fishbane S, Durham JH, Marzo K, Rudnick M (2004) N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 15(2):251\u2013260","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"626_CR26","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ehj.2003.11.011","volume":"25","author":"I Goldenberg","year":"2004","unstructured":"Goldenberg I, Shechter M, Matetzky S, Jonas M, Adam M, Pres H, Elian D, Agranat O, Schwammenthal E, Guetta V (2004) Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature. Eur Heart J 25(3):212\u2013218","journal-title":"Eur Heart J"},{"issue":"6","key":"626_CR27","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/hrt.2004.039636","volume":"91","author":"VO Gomes","year":"2005","unstructured":"Gomes VO, Poli de Figueredo CE, Caramori P, Lasevitch R, Bodanese LC, Ara\u00fajo A, R\u00f6edel AP, Caramori AP, Brito FSJ, Bezerra HG, Nery P, Brizolara A (2005) N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial. Heart 91(6):774\u2013778","journal-title":"Heart"},{"key":"626_CR28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1741-7015-5-32","volume":"5","author":"DA Gonzales","year":"2007","unstructured":"Gonzales DA, Norsworthy KJ, Kern SJ, Banks S, Sieving PC, Star RA, Natanson C, Danner RL (2007) A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity. BMC Med:5\u201332","journal-title":"BMC Med"},{"issue":"3","key":"626_CR29","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1148\/radiol.2353040726","volume":"253","author":"MC Heinrich","year":"2005","unstructured":"Heinrich MC, Kuhlmann MK, Grgic A, Heckmann M, Kramann B, Uder M (2005) Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro. Radiology 253(3):843\u2013849","journal-title":"Radiology"},{"issue":"2","key":"626_CR30","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1523-1755.2003.00783.x","volume":"63","author":"SN Heyman","year":"2003","unstructured":"Heyman SN, Goldfarb M, Shina A, Karmeli F, Rosen S (2003) N-acetylcysteine ameliorates renal microcirculation: studies in rats. Kidney Int 63(2):634\u2013641","journal-title":"Kidney Int"},{"issue":"4","key":"626_CR31","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/ndt\/13.4.911","volume":"13","author":"I Hizoh","year":"1998","unstructured":"Hizoh I, Strater J, Schick CS, Kubler W, Haller C (1998) Radiocontrast-induced DNA fragmentation of renal tubular cells in vitro: role of hypertonicity. Nephrol Dial Transpl 13(4):911\u2013918","journal-title":"Nephrol Dial Transpl"},{"issue":"45","key":"626_CR32","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1038\/sj.onc.1203129","volume":"18","author":"H Ichijo","year":"1999","unstructured":"Ichijo H (1999) From receptors to stress-activated MAP kinases. Oncogene 18(45):6087\u20136093","journal-title":"Oncogene"},{"issue":"2","key":"626_CR33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0955-0674(98)80143-9","volume":"10","author":"YT Ip","year":"1998","unstructured":"Ip YT, Davis RJ (1998) Signal transduction by the c-Jun N-terminal kinase (JNK)\u2014from inflammation to development. Curr Opin Cell Biol 10(2):205\u2013219","journal-title":"Curr Opin Cell Biol"},{"issue":"12","key":"626_CR34","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.amjcard.2003.08.059","volume":"92","author":"DW Isenbarger","year":"2003","unstructured":"Isenbarger DW, Kent SM, O\u2019Malley PG (2003) Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy. Am J cardiol 92(12):1454\u20131458","journal-title":"Am J cardiol"},{"issue":"3","key":"626_CR35","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ahj.2008.11.010","volume":"157","author":"SH Jo","year":"2009","unstructured":"Jo SH, Koo BK, Park JS, Kang HJ, Kim YJ, Kim HL, Chae IH, Choi DJ, Sohn DW, Oh BH, Park YB, Choi YS, Kim HS (2009) N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study\u2014a prospective randomized controlled trial. Am Heart J 157(3):576\u2013583","journal-title":"Am Heart J"},{"issue":"1","key":"626_CR36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/ajkd.1998.v32.pm9669426","volume":"32","author":"RE Katholi","year":"1998","unstructured":"Katholi RE, Woods WTJ, Taylor GJ, Deitrick CL, Womack KA, Katholi CR, McCann WP (1998) Oxygen free radicals and contrast nephropathy. Am J Kidney Dis 32(1):64\u201371","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"626_CR37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.289.5.553","volume":"289","author":"J Kay","year":"2003","unstructured":"Kay J, Chow WH, Chan TM, Lo SK, Kwok OH, Yip A, Fan K, Lee CH, Lam WF (2003) Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 289(5):553\u2013558","journal-title":"JAMA"},{"issue":"4","key":"626_CR38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.7326\/0003-4819-148-4-200802190-00007","volume":"148","author":"AM Kelly","year":"2008","unstructured":"Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC (2008) Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 148(4):284\u2013294","journal-title":"Ann Intern Med"},{"key":"626_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bss0660001","volume":"66","author":"G Kroemer","year":"1999","unstructured":"Kroemer G (1999) Mitochondrial control of apoptosis: an overview. Biochem Soc Symp 66:1\u201315","journal-title":"Biochem Soc Symp"},{"issue":"3","key":"626_CR40","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/01.ASN.0000116241.47678.49","volume":"15","author":"AV Kshirsagar","year":"2004","unstructured":"Kshirsagar AV, Poole C, Mottl A, Shoham D, Franceschini N, Tudor G, Agrawal M, Denu-Ciocca C, Magnus Ohman E, Finn WF (2004) N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol 15(3):761\u2013769","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"626_CR41","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1152\/physrev.2001.81.2.807","volume":"81","author":"JM Kyriakis","year":"2001","unstructured":"Kyriakis JM, Avruch J (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81(2):807\u2013869","journal-title":"Physiol Rev"},{"issue":"6476","key":"626_CR42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/369156a0","volume":"369","author":"JM Kyriakis","year":"1994","unstructured":"Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369(6476):156\u2013160","journal-title":"Nature"},{"issue":"5","key":"626_CR43","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1073\/pnas.0438011100","volume":"100","author":"K Lei","year":"2003","unstructured":"Lei K, Davis RJ (2003) JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci USA 100(5):2432\u20132437","journal-title":"Proc Natl Acad Sci USA"},{"issue":"26","key":"626_CR44","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1056\/NEJMoa054209","volume":"354","author":"G Marenzi","year":"2006","unstructured":"Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, De Metrio M, Galli S, Fabbiocchi F, Montorsi P, Veglia F, Bartorelli AL (2006) N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 354(26):2773\u20132782","journal-title":"N Engl J Med"},{"issue":"15","key":"626_CR45","first-page":"1419","volume":"51","author":"PA McCullough","year":"2008","unstructured":"McCullough PA (2008) Contrast-induced acute kidney injury. JAMA 51(15):1419\u20131428","journal-title":"JAMA"},{"issue":"1","key":"626_CR46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1020675721351","volume":"240","author":"A Mehta","year":"2002","unstructured":"Mehta A, Sekhon CPS, Giri S, Orak JK, Singh AK (2002) Attenuation of ischemia\/reperfusion induced MAP kinases by N-acetyl cysteine, sodium nitroprusside and phosphoramidon. Mol Cell Biochem 240(1):19\u201329","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"626_CR47","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ahj.2004.05.015","volume":"148","author":"SE Miner","year":"2004","unstructured":"Miner SE, Dzavik V, Nguyen-Ho P, Richardson R, Mitchell J, Atchison D, Seidelin P, Daly P, Ross J, McLaughlin PR, Ing D, Lewycky P, Barolet A, Schwartz L (2004) N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up. Am Heart J 148(4):690\u2013695","journal-title":"Am Heart J"},{"issue":"12","key":"626_CR48","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.amjmed.2004.06.046","volume":"117","author":"BK Nallamothu","year":"2004","unstructured":"Nallamothu BK, Shojania KG, Saint S, Hofer TP, Humes HD, Moscucci M, Bates ER (2004) Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. Am J Med 117(12):938\u2013947","journal-title":"Am J Med"},{"issue":"6","key":"626_CR49","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1016\/S0002-8703(03)00511-8","volume":"146","author":"JB Oldemeyer","year":"2003","unstructured":"Oldemeyer JB, Biddle WP, Wurdeman RL, Mooss AN, Cichowski E, Hilleman DE (2003) Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography. Am Heart J 146(6):E23","journal-title":"Am Heart J"},{"issue":"3","key":"626_CR50","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ahj.2007.05.012","volume":"154","author":"EE Ozcan","year":"2007","unstructured":"Ozcan EE, Guneri S, Akdeniz B, Akyildiz IZ, Senaslan O, Baris N, Aslan O, Badak O (2007) Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Am Heart J 154(3):539\u2013544","journal-title":"Am Heart J"},{"issue":"4","key":"626_CR51","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1523-1755.2004.00516.x","volume":"65","author":"N Pannu","year":"2004","unstructured":"Pannu N, Manns B, Lee H, Tonelli M (2004) Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int 65(4):1366\u20131374","journal-title":"Kidney Int"},{"issue":"23","key":"626_CR52","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1001\/jama.295.23.2765","volume":"295","author":"N Pannu","year":"2006","unstructured":"Pannu N, Wiebe N, Tonelli M, Network AKD (2006) Prophylaxis strategies for contrast-induced nephropathy. JAMA 295(23):2765\u20132779","journal-title":"JAMA"},{"key":"626_CR53","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/sj.ki.5000367","volume":"100","author":"PB Persson","year":"2006","unstructured":"Persson PB, Tepel M (2006) Contrast medium-induced nephropathy: the pathophysiology. Kidney Int Suppl 100:S8\u2013S10","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"626_CR54","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.2215\/CJN.01560408","volume":"3","author":"T Rehman","year":"2008","unstructured":"Rehman T, Fought J, Solomon R (2008) N-acetylcysteine effect on serum creatinine and cystatin C levels in CKD patients. Clin J Am Soc Nephrol 3(6):1610\u20131614","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"626_CR55","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrm2153","volume":"8","author":"SJ Riedl","year":"2007","unstructured":"Riedl SJ, Salvesen GS (2007) The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 8(5):405\u2013413","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"626_CR56","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0955-0674(97)80061-0","volume":"9","author":"MJ Robinson","year":"1997","unstructured":"Robinson MJ, Cobb MH (1997) Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9(2):180\u2013186","journal-title":"Curr Opin Cell Biol"},{"issue":"20","key":"626_CR57","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehn197","volume":"29","author":"G Romano","year":"2008","unstructured":"Romano G, Briguori C, Quintavalle C, Zanca C, Rivera NV, Colombo A, Condorelli G (2008) Contrast agents and renal cell apoptosis. Eur Hearth J 29(20):2569\u20132576","journal-title":"Eur Hearth J"},{"issue":"12","key":"626_CR58","first-page":"1273","volume":"2","author":"RR Rosato","year":"2003","unstructured":"Rosato RR, Almenara JA, Dai Y, Grant S (2003) Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells. Mol Cancer Ther 2(12):1273\u20131284","journal-title":"Mol Cancer Ther"},{"issue":"25","key":"626_CR59","doi-asserted-by":"crossref","first-page":"17941","DOI":"10.1074\/jbc.274.25.17941","volume":"274","author":"A Saleh","year":"1999","unstructured":"Saleh A, Srinivasula SM, Acharya S, Fishel R, Alnemri ES (1999) Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J Biol Chem 274(25):17941\u201317945","journal-title":"J Biol Chem"},{"issue":"4","key":"626_CR60","first-page":"478","volume":"23","author":"F Sar","year":"2010","unstructured":"Sar F, Saler T, Ecebay A, Saglam ZA, Ozturk S, Kazancioglu R (2010) The efficacy of n-acetylcysteine in preventing contrast-induced nephropathy in type 2 diabetic patients without nephropathy. J Nephrol 23(4):478\u2013482","journal-title":"J Nephrol"},{"issue":"2","key":"626_CR61","doi-asserted-by":"crossref","first-page":"R335","DOI":"10.1152\/ajpregu.00605.2001","volume":"282","author":"CG Schnackenberg","year":"2002","unstructured":"Schnackenberg CG (2002) Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am J Physiol Regul Integr Comp Physiol 282(2):R335\u2013R342","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"626_CR62","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1056\/NEJM198901193200304","volume":"320","author":"SJ Schwab","year":"1989","unstructured":"Schwab SJ, Hlatky MA, Pieper KS, Davidson CJ, Morris KG, Skelton TN, Bashore TM (1989) Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 320(3):149\u2013153","journal-title":"N Engl J Med"},{"issue":"12","key":"626_CR63","first-page":"948","volume":"117","author":"SJ Shah","year":"2004","unstructured":"Shah SJ, Hsu CY (2004) Has acetylcysteine use changed the incidence of contrast nephropathy in hospitalized patients? A before-after study. Am Heart J 117(12):948\u2013952","journal-title":"Am Heart J"},{"issue":"8","key":"626_CR64","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/hrt.2004.053579","volume":"91","author":"SJ Shalansky","year":"2005","unstructured":"Shalansky SJ, Pate GE, Levin A, Webb JG (2005) N-acetylcysteine for prevention of radiocontrast induced nephrotoxicity: the importance of dose and route of administration. Hearth 91(8):997\u2013999","journal-title":"Hearth"},{"issue":"8","key":"626_CR65","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0735-1097(02)02308-2","volume":"40","author":"KG Shyu","year":"2002","unstructured":"Shyu KG, Cheng JJ, Kuan P (2002) Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 40(8):1383\u20131388","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"626_CR66","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJM199202133260701","volume":"328","author":"EP Steinberg","year":"1992","unstructured":"Steinberg EP, Moore RD, Powe NR, Gopalan R, Davidoff AJ, Litt M, Graziano S, Brinker JA (1992) Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography. N Engl J Med 328(7):425\u2013430","journal-title":"N Engl J Med"},{"key":"626_CR67","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.biochem.69.1.217","volume":"69","author":"A Strasser","year":"2000","unstructured":"Strasser A, O\u2019Connor L, Dixit VM (2000) Apoptosis signaling. Annu Rev Biochem 69:217\u2013245","journal-title":"Annu Rev Biochem"},{"issue":"6","key":"626_CR68","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1046\/j.1523-1755.2003.00301.x","volume":"64","author":"T Tanaka","year":"2003","unstructured":"Tanaka T, Miyata T, Inagi R, Kurokawa K, Adler S, Fujita T, Nangaku M (2003) Hypoxia-induced apoptosis in cultured glomerular endothelial cells: involvement of mitochondrial pathways. Kidney Int 64(6):2020\u20132032","journal-title":"Kidney Int"},{"issue":"4","key":"626_CR69","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/ndt\/14.4.923","volume":"14","author":"M Tariq","year":"1999","unstructured":"Tariq M, Morais C, Sobki S, Al Sulaiman M, Al Khader A (1999) N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats. Nephrol Dial Transpl 14(4):923\u2013929","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"626_CR70","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJM200007203430304","volume":"343","author":"M Tepel","year":"2000","unstructured":"Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343(3):180\u2013184","journal-title":"N Engl J Med"},{"key":"626_CR74","doi-asserted-by":"crossref","unstructured":"Trivedi H, Daram S, Szabo A, Bartorelli AL, Marenzi G (2009) High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy. Am J Med 122(9):874.e9\u2013874.e15","DOI":"10.1016\/j.amjmed.2009.01.035"},{"issue":"6A","key":"626_CR71","doi-asserted-by":"crossref","first-page":"14K","DOI":"10.1016\/j.amjcard.2006.01.020","volume":"98","author":"J Tumlin","year":"2006","unstructured":"Tumlin J, Stacul F, Adam A, Becker CR, Davidson C, Lameire N, McCullough PA, Panel CCW (2006) Pathophysiology of contrast-induced nephropathy. Am J Cardiol 98(6A):14K\u201320K","journal-title":"Am J Cardiol"},{"issue":"53","key":"626_CR72","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1038\/sj.onc.1207232","volume":"22","author":"S Wang","year":"2003","unstructured":"Wang S, El-Deiry WS (2003) TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 22(53):8628\u20138633","journal-title":"Oncogene"},{"issue":"3","key":"626_CR73","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ahj.2004.03.041","volume":"148","author":"JG Webb","year":"2004","unstructured":"Webb JG, Pate GE, Humphries KH, Buller CE, Shalansky S, Al Shamari A, Sutander A, Williams T, Fox RS, Levin A (2004) A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect. Am Heart J 148(3):422\u2013429","journal-title":"Am Heart J"},{"issue":"2","key":"626_CR75","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V88.2.386.bloodjournal882386","volume":"88","author":"E Yang","year":"1996","unstructured":"Yang E, Korsmeyer SJ (1996) Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88(2):386\u2013401","journal-title":"Blood"},{"issue":"6","key":"626_CR76","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1046\/j.1523-1755.2003.00335.x","volume":"64","author":"T Yano","year":"2003","unstructured":"Yano T, Itoh Y, Sendo T, Kubota T, Oishi R (2003) Cyclic AMP reverses radiocontrast media-induced apoptosis in LLC-PK1 cells by activating A kinase\/PI3 kinase. Kidney Int 64(6):2052\u20132063","journal-title":"Kidney Int"},{"issue":"1","key":"626_CR77","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1523-1755.2003.00059.x","volume":"64","author":"RA Zager","year":"2003","unstructured":"Zager RA, Johnson AC, Hanson SY (2003) Radiographic contrast media-induced tubular injury: evaluation of oxidant stress and plasma membrane integrity. Kidney Int 64(1):128\u2013139","journal-title":"Kidney Int"},{"issue":"1","key":"626_CR78","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ahj.2005.01.055","volume":"151","author":"A Zagler","year":"2006","unstructured":"Zagler A, Azadpour M, Mercado C, Hennekens CH (2006) N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. Am Heart J 151(1):140\u2013145","journal-title":"Am Heart J"},{"issue":"6","key":"626_CR79","doi-asserted-by":"crossref","first-page":"H2869","DOI":"10.1152\/ajpheart.01080.2004","volume":"288","author":"L Zhu","year":"2005","unstructured":"Zhu L, He P (2005) Platelet-activating factor increases endothelial [Ca2+] i and NO production in individually perfused intact microvessels. Am J Physiol Heart Circ Physiol 288(6):H2869\u2013H2877","journal-title":"Am J Physiol Heart Circ Physiol"}],"updated-by":[{"DOI":"10.1007\/s00204-011-0647-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2011,1,21]],"date-time":"2011-01-21T00:00:00Z","timestamp":1295568000000}}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-010-0626-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-010-0626-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-010-0626-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T11:25:36Z","timestamp":1592133936000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-010-0626-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,8]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["626"],"URL":"https:\/\/doi.org\/10.1007\/s00204-010-0626-5","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00204-011-0647-8","asserted-by":"object"}]},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,8]]}}}